Compounds > levodopa
Page last updated: 2024-08-17

levodopa and neocuproine

levodopa has been researched along with neocuproine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Safavi, A; Tohidi, M1
Alharrasi, A; Ashraf, GM; Damanhouri, GA; Hadi, SM; Khan, HY; Perveen, A; Tabrez, S1
Arif, H; Hadi, SM; Rehmani, N; Wani, AA; Zafar, A1

Other Studies

3 other study(ies) available for levodopa and neocuproine

ArticleYear
Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method.
    Journal of pharmaceutical and biomedical analysis, 2007, May-09, Volume: 44, Issue:1

    Topics: Antiparkinson Agents; Carbidopa; Ethanol; Excipients; Hydrogen-Ion Concentration; Kinetics; Levodopa; Osmolar Concentration; Oxidation-Reduction; Pharmaceutical Preparations; Phenanthrolines; Sensitivity and Specificity; Solubility; Spectrophotometry; Surface-Active Agents; Tablets; Temperature

2007
Pro-oxidant DNA breakage induced by the interaction of L-DOPA with Cu(II): a putative mechanism of neurotoxicity.
    Advances in experimental medicine and biology, 2015, Volume: 822

    Topics: Antiparkinson Agents; Chelating Agents; Comet Assay; Copper; DNA Breaks; Humans; Hydroxyl Radical; Levodopa; Lymphocytes; Neurotoxicity Syndromes; Oxidation-Reduction; Phenanthrolines; Reactive Oxygen Species; Superoxides

2015
Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: A pro-oxidant mechanism.
    Toxicology in vitro : an international journal published in association with BIBRA, 2017, Volume: 40

    Topics: Cell Line; Cell Line, Tumor; Chelating Agents; Copper; DNA Damage; Dopamine; Dopamine Agents; Humans; Levodopa; Lymphocytes; Oxidation-Reduction; Phenanthrolines; Reactive Oxygen Species

2017